Biomedical Engineering Reference
In-Depth Information
82. Vila A, Sanchez A, Tobio M, Calvo P, Alonso MJ (2002) Design of biodegradable particles
for protein delivery. J Control Release 78(1-3):15-24
83. Garbayo E, Ansorena E, Lanciego JL, Aymerich MS, Blanco-Prieto MJ (2008) Sustained
release
of
bioactive
glycosylated
glial
cell-line
derived
neurotrophic
factor
from
biodegradable polymeric microspheres. Eur J Pharm Biopharm 69(3):844-851
84. Lee J, Bhang SH, Park H, Kim BS, Lee KY (2010) Active blood vessel formation in the
ischemic hindlimb mouse model using a microsphere/hydrogel combination system. Pharm
Res 27(5):767-774
85. Sun Q, Silva EA, Wang A, Fritton JC, Mooney DJ, Schaffler MB, Grossman PM,
Rajagopalan S (2010) Sustained release of multiple growth factors from injectable
polymeric system as a novel therapeutic approach towards angiogenesis. Pharm Res
27(2):264-271
86. Golub JS, Kim YT, Duvall CL, Bellamkonda RV, Gupta D, Lin AS, Weiss D, Guldberg TW,
Robert RE (2010) Sustained VEGF delivery via PLGA nanoparticles promotes vascular
growth. Am J Physiol Heart Circ Physiol 298(6):H1959-H1965
87. Brar BK, Stephanou A, Wagstaff MJ, Coffin RS, Marber MS, Engelmann G, Latchman DS
(1999) Heat shock proteins delivered with a virus vector can protect cardiac cells against
apoptosis as well as against thermal or hypoxic stress. J Mol Cell Cardiol 31(1):135-146
88. Laham RJ, Sellke FW, Edelman ER, Pearlman JD, Ware JA, Brown DL, Gold JP, Simons M
(1999) Local perivascular delivery of basic fibroblast growth factor in patients undergoing
coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled
trial. Circulation 100(18):1865-1871
89. Laflamme MA, Murry CE (2011) Heart regeneration. Nature 473(7347):326-335
90. Murry CE, Reinecke H, Pabon LM (2006) Regeneration gaps: observations on stem cells
and cardiac repair. J Am Coll Cardiol 47(9):1777-1785
91. Whelan RS, Kaplinskiy V, Kitsis RN (2010) Cell death in the pathogenesis of heart disease:
mechanisms and significance. Annu Rev Physiol 72:19-44
92. Jezierska-Wozniak K, Mystkowska D, Tutas A, Jurkowski MK (2011) Stem cells as therapy
for cardiac disease:a review. Folia Histochem Cytobiol 49(1):13-25
93. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA, Glower DD,
Kraus
WE
(1998)
Regenerating
functional
myocardium:
improved
performance
after
skeletal myoblast transplantation. Nat Med 4(8):929-933
94. Menasche P, Alfieri O, Janssens S, McKenna W, Reichenspurner H, Trinquart L, Vilquin JT,
Marolleau JP, Seymour B, Larghero J, Lake S, Chatellier G, Solomon S, Desnos M,
Hagege AA (2008) The Myoblast Autologous Grafting in Ischemic Cardiomyopathy
(MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.
Circulation 117(9):1189-1200
95. Winitsky SO, Gopal TV, Hassanzadeh S, Takahashi H, Gryder D, Rogawski MA, Takeda K,
Yu ZX, Xu YH, Epstein ND (2005) Adult murine skeletal muscle contains cells that can
differentiate into beating cardiomyocytes in vitro. PLoS Biol 3(4):e87
96. Menasche P (2007) Skeletal myoblasts as a therapeutic agent. Prog Cardiovasc Dis
50(1):7-17
97. Dib N, Michler RE, Pagani FD, Wright S, Kereiakes DJ, Lengerich R, Binkley P, Buchele D,
Anand I, Swingen C, Di Carli MF, Thomas JD, Jaber WA, Opie SR, Campbell A, McCarthy P,
Yeager M, Dilsizian V, Griffith BP, Korn R, Kreuger SK, Ghazoul M, MacLellan WR,
Fonarow G, Eisen HJ, Dinsmore J, Diethrich E (2005) Safety and feasibility of autologous
myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up.
Circulation 112(12):1748-1755
98. Mozid AM, Arnous S, Sammut EC, Mathur A (2011) Stem cell therapy for heart diseases.
Br Med Bull 98:143-159
99. He KL, Yi GH, Sherman W, Zhou H, Zhang GP, Gu A, Kao R, Haimes HB, Harvey J, Roos E,
White D, Taylor DA, Wang J, Burkhoff D (2005) Autologous skeletal myoblast
transplantation improved hemodynamics and left ventricular function in chronic heart
failure dogs. J Heart Lung Transplant 24(11):1940-1949
